Literature DB >> 14680799

High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form.

Joachim Kuhn1, Sandra Müller, Martina Schnölzer, Tore Kempf, Sylvia Schön, Thomas Brinkmann, Manuela Schöttler, Christian Götting, Knut Kleesiek.   

Abstract

Human xylosyltransferase I (XT-I) catalyzes the transfer of xylose from UDP-xylose to consensus serine residues of proteoglycan core proteins. Expression of a soluble form of recombinant histidine-tagged XT-I (rXT-I-HIS) was accomplished at a high level with High Five/pCG255-1 insect cells in suspension culture. The recombinant protein was purified to homogeneity by a combination of heparin affinity chromatography and metal (Ni(2+)) chelate affinity chromatography. Using the modern technique of perfusion chromatography, a rapid procedure for purification of the rXT-I-HIS from insect cell culture supernatant was developed. The purified, biologically active enzyme was homogeneous on SDS-PAGE, was detected with anti-XT-I-antibodies, and had the expected tryptic fragment mass spectrum. N-terminal amino acid sequencing demonstrated that the N-terminal signal sequence of the expressed protein was quantitatively cleaved. The total yield of the enzyme after purification was 18% and resulted in a specific XT-I activity of 7.9mU/mg. The K(m) of the enzyme for recombinant [Val(36),Val(38)](delta1),[Gly(92),Ile(94)](delta2)bikunin was 0.8microM. About 5mg purified enzyme could be obtained from 1L cell culture supernatant. The availability of substantial quantities of active, homogeneous enzyme will be of help in future biochemical and biophysical characterization of XT-I and for the development of a immunological XT-I assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680799     DOI: 10.1016/j.bbrc.2003.10.157

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Comparative characterisation of recombinant invertebrate and vertebrate peptide O-Xylosyltransferases.

Authors:  Andrea Brunner; Daniel Kolarich; Josef Voglmeir; Katharina Paschinger; Iain B H Wilson
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

2.  Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme.

Authors:  Sandra Müller; Jennifer Disse; Manuela Schöttler; Sylvia Schön; Christian Prante; Thomas Brinkmann; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

3.  Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.

Authors:  Sandra Müller; Manuela Schöttler; Sylvia Schön; Christian Prante; Thomas Brinkmann; Joachim Kuhn; Christian Götting; Knut Kleesiek
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

4.  Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.

Authors:  Joachim Kuhn; Christian Götting; Brendan J Beahm; Carolyn R Bertozzi; Isabel Faust; Patricia Kuzaj; Cornelius Knabbe; Doris Hendig
Journal:  Biochem Biophys Res Commun       Date:  2015-03-03       Impact factor: 3.575

5.  XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity.

Authors:  Josef Voglmeir; Regina Voglauer; Iain B H Wilson
Journal:  J Biol Chem       Date:  2006-12-28       Impact factor: 5.157

Review 6.  Recent advances on glycosyltransferases involved in the biosynthesis of the proteoglycan linkage region.

Authors:  Jia Gao; Xuefei Huang
Journal:  Adv Carbohydr Chem Biochem       Date:  2021-11-24       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.